share_log

UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5

UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5

瑞银以中性评级启动对Pediatrix医疗集团的保险,宣布目标股价为9.5美元
Benzinga ·  2023/11/30 08:43

UBS analyst A.J. Rice initiates coverage on Pediatrix Medical Group (NYSE:MD) with a Neutral rating and announces Price Target of $9.5.

瑞银分析师A.J. Rice以中性评级开始对Pediatrix Medical Group(纽约证券交易所代码:MD)进行报道,并宣布目标股价为9.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发